Henry Waxman

Earlier this month, President Obama sent to Congress a $6.2 billion supplemental budget request to enhance the U.S. Government response to the Ebola outbreak.

Well, it seems to me that it shouldn't be partisan in any way for us to give the grant of money the President has requested to deal with this terrible epidemic in Africa, and to protect Americans as well, and the request is quite balanced…

The President has asked for more money in a supplemental budget. A big portion of that is going to go to our efforts in Africa to try to stop and contain this disease.

I am pleased to yield 2 minutes to the gentleman from Missouri (Mr. Cleaver).

A ban or quarantine would hinder efforts to fight the epidemic in West Africa, and the worse the epidemic becomes in West Africa, the greater it is going to be a problem all over the world including the United States.

We have to make sure that we monitor health care workers because they are exposed to people who have Ebola.

Thank you, Mr. Chairman.

May I inquire how much time is remaining. The SPEAKER pro tempore (Mr. Womack). The gentleman from California has 47\1/2\ minutes remaining. The gentleman from Washington has 44 minutes remaining.

I believe a lot more in public investment because the pharmaceutical engineers are not going to make a lot of investment in this area when their research investments can result in a blockbuster drug.

We want to make sure they get a profit so that we want to guarantee we could take their investment, guarantee a certain percentage, and say that is how much the government will pay you.

I don't think Mr. Outterson or I thought or would want anybody to believe that we thought you don't need a profit and you don't need the private enterprise.

Well, I would suggest that we may be better off putting much more money into biomedical research at NIH and throughout universities around the country because they don't have the profit motive and what they do helps the companies because…

We have given tax credits. We want to shorten the time at FDA to get this review done as quickly as possible to get the drug out there.

So tell us how to change this economic model. You talked about that in your presentation.

Last Congress we passed the GAIN Act to provide new incentives for the development of important antibiotics.

I think it is essential that the drug bear a prominent statement describing the abbreviated pathway by which it came to market.

You have done a wonderful job at the FDA, and your responses to questions from both sides of the aisle have been very, very thoughtful.

I would like to ask unanimous consent that a statement prepared by Congresswoman Louise Slaughter be included in the record.

I have a bill that would finally give the public access to this information, H.R. 820, the DATA Act.

I hope we will discuss today another approach to getting new antibiotics on the market.

Regaining the trust of consumers worldwide is crucial to the continued growth of Internet and communications technology sector in the United States.

One way to help alleviate those fears and build trust is for the United States to establish effective baseline privacy and data security protections.

There is no doubt that foreign trust in the United States Government and of U.S.-based companies has been hurt by revelations since last year about the NSA's online surveillance programs.

With these types of efforts, we can educate, train, and employ African Americans and other minorities so that they too can enjoy the economic benefits of the American energy boom.

I strongly supported this effort. It would have created good, clean energy jobs for local residents while also helping low-income families save money on the energy bills through energy efficiency upgrades.